Patents Assigned to National Institute of Health and Medical Research
  • Triheptanoin for the treatment of glucose transport 1 deficiency
    Patent number: 10111848
    Abstract: Provided are methods for treating GLUT1 and related brain energy deficiencies comprising administering odd-carbon fatty acid sources, e.g., C5 or C7 fatty acid sources, and related compositions.
    Type: Grant
    Filed: September 6, 2016
    Date of Patent: October 30, 2018
    Assignees: National Institute of Health and Medical Research, Baylor Research Institute
    Inventors: Fanny Mochel, Raphael Schiffmann
  • Triheptanoin for the treatment of glucose transport 1 deficiency
    Patent number: 9468229
    Abstract: Provided are methods for treating GLUT1 and related brain energy deficiencies comprising administering odd-carbon fatty acid sources, e.g., C5 or C7 fatty acid sources, and related compositions.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: October 18, 2016
    Assignees: NATIONAL INSTITUTE OF HEALTH AND MEDICAL RESEARCH, BAYLOR RESEARCH INSTITUTE
    Inventors: Fanny Mochel, Raphael Schiffmann
  • TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORT 1 DEFICIENCY
    Publication number: 20140221482
    Abstract: Provided are methods for treating GLUT1 and related brain energy deficiencies comprising administering odd-carbon fatty acid sources, e.g., C5 or C7 fatty acid sources, and related compositions.
    Type: Application
    Filed: December 13, 2013
    Publication date: August 7, 2014
    Applicants: Baylor Research Institute at Dallas, National Institute of Health and Medical Research
    Inventors: Fanny Mochel, Raphael Schiffmann
  • Phorbine derivatives and their use in the diagnosis and therapy of cancer
    Patent number: 5492924
    Abstract: Phorbine derivatives having high potency and light absorptivity in the 650 to 780 nanometer range are useful in cancer diagnosis and therapy, especially photodynamic therapy.
    Type: Grant
    Filed: September 24, 1993
    Date of Patent: February 20, 1996
    Assignees: Fox Chase Cancer Center, The French National Institute of Health and Medical Research (Inserm), Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Shimon Gatt, Arie Dagan, Rene Santus, Jean-Claude Maziere, J. Donald Chapman, Edward L. Engelhardt